Local drugmakers oppose hospital incentive plan

The Korea Pharmaceutical Manufacturers Association (KPMA) and the government have clashed over a new incentive plan, under which a medical institution can get paid the rebate by the government when the institution purchases a drug at a cheaper price than the standard price.

The government plans to hold a public information session within this month in its bid to adopt the measure, but the KP...